- CDC
- Heart Failure
- Cardiovascular Clinical Consult
- Adult Immunization
- Hepatic Disease
- Rare Disorders
- Pediatric Immunization
- Implementing The Topcon Ocular Telehealth Platform
- Weight Management
- Screening
- Monkeypox
- Guidelines
- Men's Health
- Psychiatry
- Allergy
- Nutrition
- Women's Health
- Cardiology
- Substance Use
- Pediatrics
- Kidney Disease
- Genetics
- Complimentary & Alternative Medicine
- Dermatology
- Endocrinology
- Oral Medicine
- Otorhinolaryngologic Diseases
- Pain
- Gastrointestinal Disorders
- Geriatrics
- Infection
- Musculoskeletal Disorders
- Obesity
- Rheumatology
- Technology
- Cancer
- Nephrology
- Anemia
- Neurology
- Pulmonology
Strengthen the Response to Iron Therapy
When a patient with iron deficiency anemia fails to respond to oral iron supplementation, consider whether foods he or she is consuming may be contributing to malabsorption. Such foods include coffee and tea (because they contain tannins) and cola drinks (a result of their phosphate content). In addition, because achlorhydria may interfere with iron absorption, encourage patients to eat foods rich in vitamin
When a patient with iron deficiency anemia fails to respond to oral iron supplementation, consider whether foods he or she is consuming may be contributing to malabsorption. Such foods include coffee and tea (because they contain tannins) and cola drinks (a result of their phosphate content). In addition, because achlorhydria may interfere with iron absorption, encourage patients to eat foods rich in vitamin C-or even take vitamin C supplements-before you decide that oral iron supplementation has failed.
-- Prashant Vaishnava, MD Boston
For more tips, check out our Practical Pointers archives.
Would you find this Pointer helpful in your practice?
Email your comment to us
Breakthrough at ACG 2013: Oral-Only Treatment for Chronic Hepatitis C
October 17th 2013Data from pivotal international phase III clinical trials showed superior efficacy, safety, and convenience for a new wave of direct-acting oral agents. The breakthrough will benefit physicians in all practice settings, including primary care.
